Combined Effects of Non-Statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2016
At a glance
- Drugs Atorvastatin; Choline fenofibrate; Niacin
- Indications Dyslipidaemias
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms CENTAUR
- 31 Aug 2018 Biomarkers information updated
- 28 Jan 2016 According to ClinicalTrials.gov record,number of treatment arms changed from 1 to 3.
- 18 Dec 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.